Travel cap
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
The features shown in broken lines within the opening in
Claims
The ornamental design for a travel cap, as shown and described.
Referenced Cited
Patent History
Patent number: D748398
Type: Grant
Filed: Nov 25, 2013
Date of Patent: Feb 2, 2016
Assignee: Glaxo Group Limited (Brentford, Middlesex)
Inventors: Marcus Blachford (Warwick), Alex Brian (Weybridge), Charles Drury (Warwick), Rhodri Jones (Warwick), Peter Kay (Warwick), William Knight (Warwick)
Primary Examiner: Melanie H Tung
Assistant Examiner: Lavone D Tabor
Application Number: 29/473,597
Type: Grant
Filed: Nov 25, 2013
Date of Patent: Feb 2, 2016
Assignee: Glaxo Group Limited (Brentford, Middlesex)
Inventors: Marcus Blachford (Warwick), Alex Brian (Weybridge), Charles Drury (Warwick), Rhodri Jones (Warwick), Peter Kay (Warwick), William Knight (Warwick)
Primary Examiner: Melanie H Tung
Assistant Examiner: Lavone D Tabor
Application Number: 29/473,597
Classifications
Current U.S. Class:
D4/113